This week we have packed our newsletter with all the best of the recent 72nd ADA Scientific Sessions in Philadelphia. Steve and Andrew conducted more than 20 interviews with top diabetes thought leaders and we will have those for you in the upcoming weeks. This week we looked at how …
Read More »Diabetes In Control
Avandia, Actos May Raise Risk of Macular Edema
Pioglitazone (Actos) and rosiglitazone (Avandia) appear to substantially boost risk of macular edema in type 2 diabetes, an observational study found. Incidence of diabetic macular edema was 1.3% at 1 year on a thiazolidinedione (TZD) compared with just 0.2% among type 2 diabetes patients not on one of those agents. …
Read More »Fish Oil Fails to Reduce CV Event Risk
Omega-3 fatty acids did not reduce the rate of cardiovascular events in high-risk patients with prediabetes or diabetes followed for half a dozen years, the randomized ORIGIN trial found. Cardiovascular deaths occurred among 9.1% and 9.3% of those randomized to n-3 fatty acids or placebo, respectively. N Engl J Med 2012
Read More »Statins Sap Energy
Statin drugs may leave users — especially women — feeling drained and tired on exertion, a clinical trial suggested. Combined scores for change in energy and exertional fatigue worsened after starting a statin compared with placebo (P=0.005). For women, scores suggested that as many as 40% felt more tired and …
Read More »ADA: Question Answered on Heart or Cancer Risk from Daily Insulin Glargine Use
Daily insulin glargine injections, begun during the early stages of type 2 diabetes, neither increased nor reduced the risk of heart attacks, strokes, cancer or cardiovascular-related mortality, researchers found in the largest and longest study of its kind….
Read More »ADA: Aggressive Treatment with Insulin for Pre-Diabetes
The ORIGIN study also examined whether daily insulin use in people at high risk for type 2 diabetes would prevent or slow progression of the disease….
Read More »ADA: Old Anti-Inflammatory Drug Found to Lower Blood Glucose Levels in People with Type 2 Diabetes
In a modern-day clinical trial of a medicine belonging to one of the world’s oldest classes of drugs, researchers have found that a drug related to aspirin and salicylate, may be a potential treatment for people with type 2 diabetes….
Read More »ADA: Children with Type 2 Diabetes Progress More Rapidly to Complications than Those Diagnosed as Adults
Many are unable to control A1c and many develop markers of risk for cardiovascular complications….
Read More »ADA: First U.S. Type 1 Registry with 25,000 Participants Publishes Results
In the most comprehensive analysis of people with type 1 diabetes ever undertaken in the U.S., researchers found that….
Read More »ADA: First Meal of the Day Decreases Risk for Type 2 Diabetes
Eating breakfast is associated with a decreased chance of developing type 2 diabetes….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.